Erythropoietin receptors: Their role beyond erythropoiesis

Nephrology Dialysis Transplantation

Volumn 20, Issue , 2005, Pages 1025-1028

  Rossert, Jerome ^a   Eckardt, Kai Uwe ^b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antiapoptotic effects; Embryogenesis; Erythropoietin; Erythropoietin receptors; Organ injuries; Protective effects

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 70; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; PROTEIN BAD; PROTEIN BCL XL; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXO; X LINKED INHIBITOR OF APOPTOSIS;

ANEMIA; ANGIOGENESIS; BRAIN DEVELOPMENT; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG PENETRATION; EDITORIAL; EMBRYO DEVELOPMENT; ERYTHROPOIESIS; HEART DEVELOPMENT; HEART INJURY; HEART PROTECTION; HUMAN; KIDNEY INJURY; NERVOUS SYSTEM INJURY; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RENAL PROTECTION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; DNA-BINDING PROTEINS; EPOETIN ALFA; ERYTHROPOIESIS; ERYTHROPOIETIN; HEMATINICS; HUMANS; KIDNEY; MILK PROTEINS; RECEPTORS, ERYTHROPOIETIN; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 20844450249     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh800     Document Type: Editorial

References (30)

1. Lacombe C, Mayeux P. The molecular biology of erythropoietin. Nephrol Dial Transplant 1999; 14 [Suppl 2]: 22-28
2. Digicaylioglu M, Bichet S, Marti HH et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 1995; 92: 371-372
3. Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 1998; 52: 235-249
4. Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe ML. Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 1999; 126: 3597-3605
5. Yu X, Shacka JJ, Eells JB et al. Erythropoietin receptor signalling is required for normal brain development. Development 2002; 129: 505-516
6. Kertesz N, Wu J, Chen TH, Sucov HM, Wu H. The role of erythropoietin in regulating angiogenesis. Dev Biol 2004; 276: 101-110
7. Sakanaka M, Wen TC, Matsuda S et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998; 95: 4635-4640
8. Brines ML, Ghezzi P, Keenan S et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97: 10 526-10 531
9. Gorio A, Gokmen N, Erbayraktar S et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci USA 2002; 99: 9450-9455
10. Celik M, Gokmen N, Erbayraktar S et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002; 99: 2258-2263
11. Junk AK, Mammis A, Savitz SI et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 2002; 99: 10 659-10 664
12. Siren AL, Fratelli M, Brines M et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001; 98: 4044-4049
13. Agnello D, Bigini P, Villa P et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 2002; 952: 128-134
14. Bianchi R, Buyukakilli B, Brines M et al. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA 2004; 101: 823-828
15. Parsa CJ, Matsumoto A, Kim J et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 2003; 112: 999-1007
16. Moon C, Krawczyk M, Ahn D et al. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 2003; 100: 11 612-11 617
17. Calvillo L, Latini R, Kajstura J et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003; 100: 4802-4806
18. Wright GL, Hanlon P, Amin K, Steenbergen C, Murphy E, Arcasoy MO. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia reperfusion injury. FASEB J 2004; 18: 1031-1033
19. Yang CW, Li C, Jung JY et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003; 17: 1754-1755
20. Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with Epo reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004; 66: 983-989
21. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-2124
22. Gong H, Wang W, Kwon TH et al. Epo and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 2004; 66: 683-695
23. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004, 19: 348-355
24. L through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 1999; 274: 22 165-22 169
25. Kashii Y, Uchida M, Kirito K et al. A member of Forkhead family transcription factor, FKHRL1, is one of the down-stream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 2000; 96: 941-949
26. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuro-protection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001; 412: 641-647
27. Brines M, Grasso G, Fiordaliso F. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 2004; 101: 14 907-14 912
28. Leist M, Ghezzi P, Grasso G et al. Derivatives of erythropoietin that are tissue protective but not erythropoictic. Science 2004; 305: 239-242
29. Fiordaliso F, Chimenti S, Staszewsky L et al. A non-erythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci USA 2005; 102: 2046-2051
30. Ehrenreich H, Hasselblatt M, Dembowski C et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8: 495-505